Which of the following is an inhibitor of platelet aggregation?
**Core Concept**
Aspirin's mechanism of action involves the inhibition of platelet aggregation, which is a critical step in the formation of blood clots. This is achieved through the irreversible inhibition of the enzyme cyclooxygenase (COX), specifically COX-1, in platelets.
**Why the Correct Answer is Right**
Aspirin blocks the production of thromboxane A2, a potent stimulator of platelet aggregation, by inhibiting COX-1. This enzyme is responsible for converting arachidonic acid into prostaglandin H2, which is then converted to thromboxane A2 by thromboxane synthase. The inhibition of COX-1 reduces the production of thromboxane A2, leading to decreased platelet aggregation and a subsequent decrease in the formation of blood clots.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not specify a drug or compound that inhibits platelet aggregation.
* **Option B:** This option is incorrect because while it may be a medication, it is not specifically known for inhibiting platelet aggregation.
* **Option D:** This option is incorrect because it does not accurately describe a drug or compound that inhibits platelet aggregation.
**Clinical Pearl / High-Yield Fact**
Aspirin's effect on platelet aggregation is irreversible and can last for the lifespan of the platelet, which is approximately 7-10 days. This is why a single dose of aspirin can provide antiplatelet effects for an extended period.
**Correct Answer:** A. Aspirin